, Tracking Stock Market Picks
Enter Symbol:
Invivo Therapeutics Holdings (NVIV) [hlAlert]

down 21.72 %

DESIGN SOURCE INC (NVIV) rated Buy with price target $4 by Aegis Capital

Posted on: Monday,  Nov 25, 2013  11:25 AM ET by Aegis Capital

Aegis Capital rated Buy Invivo Therapeutics Holdings (NASDAQ: NVIV) on 11/25/2013. Previously Aegis Capital rated Buy Invivo Therapeutics Holdings (NASDAQ: NVIV) on
08/23/2013., when the stock price was $11.92. Since then, Invivo Therapeutics Holdings has lost 21.73% as of 12/31/2015's recent price of $9.33.
If you would have followed the previous Aegis Capital's recommendation on NVIV, you would have lost 21.72% of your investment in 860 days.

InVivo Therapeutics Holdings Corp is a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/25/2013 11:25 AM Buy
8.00 16.00
as of 12/13/2013
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/23/2013 10:25 AM Buy
11.92 28.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy